India has agreed to sell hydroxychloroquine tablets to Malaysia for use in the treatment of COVID-19 patients, a Malaysian minister told Reuters on Wednesday, with New Delhi partially lifting its bar on exports of the anti-malarial drug.
India is the world's largest producer of hydroxychloroquine, sales of which have soared across the world including in the United States, especially after President Donald Trump touted it as a potential weapon against COVID-19, the disease caused by the novel coronavirus.
New Delhi had last month put a hold on exports of hydroxychloroquine to secure supplies for itself, before agreeing this month to supply it to some of its neighbours as well as "nations who have been particularly badly affected by the pandemic".
"On 14 April, India has given permission for Malaysia to import 89,100 tablets," Malaysia's Deputy Foreign Minister Kamarudin Jaffar told Reuters on Wednesday.
"We will try to get more hydroxychloroquine tablets from India, which is also subject to stock availability."
India's foreign ministry did not immediately respond to requests for comment from Reuters.
Malaysia has been using hydroxychloroquine for mild to severe COVID-19 cases along with other drugs, according to its treatment protocol seen by Reuters.
It has the second highest number of infections of COVID-19 in Southeast Asia with nearly 5,000 cases, 82 of whom have died.
India's decision to sell the sought-after drug to Malaysia signals a turnaround in relations between the countries that had soured because of repeated criticism of some Indian policies by Mahathir Mohamad, before he resigned as Malaysia's prime minister in February.
Malaysia had asked for more than one million hydroxychloroquine tablets from India, two sources with direct knowledge of the matter told Reuters, requesting anonymity as they were not authorised to speak with the media.
"Broadly, nations will need each other to fight this pandemic," said an Indian source with direct knowledge of the discussions with Malaysia. "Globally, there will be a new alignment of relationships."
Teva Pharmaceutical Industries, IPCA Laboratories and Cadila Healthcare are among India's leading suppliers of hydroxychloroquine.
Cadila has increased production tenfold to 30 metric tonnes per month and is ready to produce more if needed, Managing Director Sharvil Patel had told Reuters last week.
Reuters
Wed Apr 15 2020
Laura Ng, who has lupus, had to call 5 pharmacies before she could find hydroxychloroquine prescription, is photographed in Seattle, Mar. 31, 2020. Ng is worried about the supply due to interest in the drug as COVID19 treatment-REUTERS/Lindsay Wasson
Sembilan petugas perubatan cedera dalam serangan ke atas hospital Lubnan
Sembilan jururawat dan petugas kesihatan cedera pada Jumaat dalam serangan Israel ke atas kawasan hospital di selatan Lubnan.
Pakar onkologi di Malaysia dijangka meningkat menjelang 2040
Sasaran itu mampu dicapai dengan penyertaan Malaysia dalam Fellowship of the Royal College of Radiologists (FRCR) dalam klinikal onkologi.
AWANI Ringkas: Banjir di Bosnia, tiada rakyat Malaysia terjejas
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
Kerajaan MADANI komited kurangkan pinjaman, defisit fiskal - PM Anwar
Kerajaan komited dalam mencapai sasaran konsolidasi fiskal secara berperingkat dengan mengurangkan hutang negara.
Polis, penyokong Imran Khan bertempur dalam protes di Islamabad
Dalam pertempuran dengan polis malam tadi, media tempatan melaporkan beberapa orang, termasuk adik perempuan Imran, ditahan.
Warga emas rugi RM108,000 terpedaya pelaburan tidak wujud
Mangsa diarahkan untuk memuat turun aplikasi Ats-Pro dan diberikan kredit wang berjumlah RM6,000 untuk membeli satu unit saham.
Aplikasi Facebook dikemas kini untuk menarik pengguna lebih muda
Ciri terbaharu ini sedang diuji di Amerika Syarikat dan Kanada.
GISB: Teknologi DNA jadi harapan rungkai isu ketidakpastian nasab
Penggunaan sains dan DNA mampu menawarkan penyelesaian tuntas dalam merungkai ketidaktentuan nasab kanak-kanak yang diselamatkan.
Belanjawan 2025 akan beri tumpuan kepada inflasi, naikkan gaji - PM Anwar
Kerajaan MADANI akan memberi tumpuan kepada isu inflasi dalam Belanjawan 2025, yang akan dibentangkan pada 18 Oktober ini.
Rangkaian pusat kanser diperluas di Kedah, Sarawak - Fadillah
Kerajaan sentiasa komited dalam memperkukuh sistem kesihatan negara, khususnya dalam meningkatkan akses kepada rawatan kanser berkualiti.
COVID-19: Tiga kes kematian dicatat, ini lima tumpuan kenyataan media KKM
Terdapat 108 kes positif COVID-19 yang sedang dirawat di Unit Rawatan Rapi (ICU), di mana 47 kes memerlukan bantuan pernafasan.
Sultan Perak, Sultan Selangor, Sultan Johor antara yang hadir ke Istana Negara
Pertemuan itu dijangka bagi membincangkan beberapa cadangan yang dipersembahkan oleh kerajaan terutamanya mengenai penularan COVID-19.
Pusat Jagaan Darul Hanan ambil langkah pengasingan penghuni, pekerja
Difahamkan seorang wanita warga emas yang baru masuk ke situ minggu lepas disahkan COVID-19 kelmarin.
COVID-19: Tiga lagi sekolah di Perak diarah tutup
Sebanyak tiga sekolah di Perak diarah tutup selama tujuh hari mulai hari ini selepas terdapat jangkitan wabak COVID-19 dalam kalangan pelajar di sekolah berkenaan.
Kluster Penjara Jawi: Seorang lagi pegawai penjara positif COVID-19
Pegawai wadar itu bertugas di blok baharu yang menjaga sekumpulan banduan yang dijangkiti COVID-19 sebelum ini.
SMK Lubuk China dan SK Telok Berembang di Melaka diarah tutup
Dua buah sekolah di Masjid Tanah, Melaka diarah tutup selepas seorang pelajar dari kedua-dua sekolah berkenaan disahkan positif COVID-19.
Cawangan utama BSN Kota Kinabalu ditutup, kakitangan positif COVID-19
Cawangan BSN ditutup bermula hari ini bagi melaksanakan kerja-kerja pembersihan menyeluruh.
Jepun tarik balik larangan perjalanan ke Malaysia, 11 negara lain
Sebelas negara lain termasuk China, Taiwan, Australia, New Zealand, Singapura dan Korea Selatan.
Maaflah jika Abah ini mula menggunakan rotan! - Muhyiddin
Katanya, selepas ini hukuman kompaun akan dikenakan tanpa mengira pangkat dan darjat terhadap mereka yang melanggar prosedur operasi standard (SOP) berkaitan COVID-19.
COVID-19: 691 kes baharu dilaporkan, majoriti di Penjara Alor Setar
Jumlah kes baharu positif COVID-19 yang dilaporkan hari ini ialah sebanyak 691.